About Klinikum Neuperlach
Die München Klinik Neuperlach ist ein Krankenhaus der Maximalversorgung der München Klinik gGmbH im Münchener Stadtteil Neuperlach und akademisches Lehrkrankenhaus der Ludwig-Maximilians-Universität München.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Helsinn Healthcare SA
4
Egetis Therapeutics
2
Aileron Therapeutics, Inc.
1
Arbeitsgemeinschaft medikamentoese Tumortherapie
1
Celgene
1
Deutsches Herzzentrum Muenchen
1
Dominik Paul Modest
1
Idorsia Pharmaceuticals Ltd.
1
Institut für Klinisch-Kardiovaskuläre Forschung GmbH
1
LMU Klinikum
1
Leipzig Heart Institute GmbH
1
Clinical Trials at Klinikum Neuperlach
During the past decade, Klinikum Neuperlach conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 5 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Safety and Efficacy of Six Months Dual Antiplatelet Therapy After Drug-Eluting Stenting
2008-09-01
2014-11-01
Unknown status
4,005
Coronary Artery Disease and Renal Failure Registry
2007-12-01
2013-05-01
Unknown status
3,352
Impact Of Eplerenone On Cardiovascular Outcomes In Patients Post Myocardial Infarction
2010-09-01
2012-10-01
Completed
1,012
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
2011-04-01
Completed
1,455
An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting
2011-07-01
2012-11-01
Completed
743
Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the "Apact" Study)
2014-03-28
2022-06-30
Completed
866
The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-03-22
Terminated
16,784
Evaluation of MGN1703 Maintenance Treatment in Patients With mCRC With Tumor Reduction During Induction Treatment
2014-09-01
2020-05-01
Unknown status
540
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Klinikum Neuperlach" #1 sponsor was "Helsinn Healthcare SA" with 4 trials, followed by "Egetis Therapeutics" with 2 trials
sponsored, "Aileron Therapeutics, Inc." with 1 trials sponsored, "Arbeitsgemeinschaft medikamentoese Tumortherapie" with 1 trials sponsored and "Celgene"
with 1 trials sponsored. Other sponsors include 4 different institutions and
companies that sponsored additional 14 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Neuperlach"
#1 collaborator was "Parexel" with 2 trials as a collaborator, "Solasia Pharma K.K." with 2 trials as a collaborator, "Amgen" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "BMBf (Federal Ministry of Education and Research)" with 1 trials as a collaborator. Other collaborators include 11 different institutions and companies that were
collaborators in the rest 21 trials.
Clinical Trials Conditions at Klinikum Neuperlach
According to Clinical.Site data, the most researched conditions in "Klinikum Neuperlach" are
"Colorectal Cancer" (3 trials), "Coronary Artery Disease" (3 trials), "Chemotherapy-Induced Nausea and Vomiting" (2 trials), "Chemotherapy-induced Nausea and Vomiting" (2 trials) and "Chemotherapy-induced Peripheral Neuropathy" (2 trials). Many other conditions were trialed in "Klinikum Neuperlach" in a lesser frequency.
Clinical Trials Intervention Types at Klinikum Neuperlach
Most popular intervention types in "Klinikum Neuperlach" are "Drug" (14 trials), "Other" (3 trials), "Combination Product" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (7 trials), "Calmangafodipir (5 µmol/kg)" (2 trials), "Dexamethasone" (2 trials), "ALRN-6924" (1 trials) and "CRT-D implantation" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Klinikum Neuperlach
The vast majority of trials in "Klinikum Neuperlach" are
18 trials for "All" genders.
Clinical Trials Status at Klinikum Neuperlach
Currently, there are NaN active trials in "Klinikum Neuperlach".
undefined are not yet recruiting,
3 are recruiting,
undefined are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 6 completed trials in Klinikum Neuperlach,
undefined suspended trials,
and 5 terminated clinical trials to date.
Out of the total trials that were conducted in Klinikum Neuperlach, 1 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 10 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 4 trials, and there were
also 1 trials that are defined as “Not Applicable".